Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

NCT03740945 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business decision to not perform this study.

Conditions

Vaginal Atrophy in Breast Cancer Patients

Interventions

DRUG: Placebo
DRUG: Prasterone (DHEA)

Sponsor

EndoCeutics Inc.

Collaborators

[object Object]